+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

U.S. Patient Engagement Solutions Market Size, Share & Trends Analysis Report by Delivery Type (Web-based, Cloud-based, On-premise), by Component, by End Use, by Application, by Therapeutic Area and Segment Forecasts, 2021-2028

  • ID: 4621741
  • Report
  • June 2021
  • Region: United States
  • 149 Pages
  • Grand View Research

FEATURED COMPANIES

  • athenahealth, Inc.
  • Force Therapeutics LLC
  • Greenway Health, LLC
  • IQVIA
  • Lincor
  • Medecision
The U.S. patient engagement solutions market size is anticipated to reach USD 14.7 Billion by 2028. The market is expected to expand at an exponential CAGR of 16.6% from 2021 to 2028. The key factors driving the growth include the rising geriatric population and the prevalence of chronic conditions.



The COVID-19 pandemic acted as a catalyst for rapid business and economic changes. Certain trends, which grew steadily in the past decades, including digital healthcare solutions, unexpectedly became omnipresent as lockdowns directed remote operations and large-scale reliance on technology. In addition, the COVID-19 pandemic has shown the importance for clinicians to have rapid and full access to a patient's history to make the best-informed decision about their care. This propelled the growth of the market for patient engagement solutions in the U.S.

For instance, in February 2020, Solutionreach, Inc. launched SR Health, an AI-based patient engagement platform for hospitals, health systems and enterprise healthcare organizations. This was followed by the addition of vaccine distribution messaging as part of its SR Health COVID-19 Communications solution, in January 2021.

A large population over the age of 60 is a key driver for the market growth, owing to the lower immunity levels and higher vulnerability to chronic conditions such as obesity, cardiac problems and cancer. In fact, as per the U.S. Census Bureau, the median age of the country’s population is estimated to reach age 43 by 2060 with just two-and-a-half working-age adults for every retirement-age individual. This indicates an aging U.S. population that is more likely to avail the best possible treatments to increase life span.

The incidence of chronic illnesses in the U.S. is also on the rise despite the availability of several effective therapies. Chronic ailments are the leading cause of disability and death and are the leading drivers of the country’s USD 3.8 trillion 12-monthly healthcare costs, according to the U.S. Centers for Disease Control and Prevention (CDC). The COVID-19 outbreak has expedited the necessity for digital solutions, highlighting the need for remote care, which is not only preferred but also essential.

Increasing adoption of mobile platforms coupled with the dissemination of uninterrupted 3G, 4G networks and emerging 5G technology, are rapidly boosting the use of mobile health. There has been an incredible upsurge in the use of mobile phones and the internet by physicians in the U.S. leading to the progress of mobile health solutions. The usage of mobile applications has proven to be very effective in spreading awareness about chronic diseases, managing personal health, communicating with healthcare providers and maintaining health records. This is expected to fuel the market growth.

U.S. Patient Engagement Solutions Market Report Highlights
  • Key factors estimated to propel the market include the aging population, rising prevalence of chronic diseases and the high adoption of digital health solutions
  • The wed-based solutions held the largest share of the delivery type segment in 2020 due to the ease of accessibility and reliability of these solutions
  • The component segment was dominated by software as it forms the core of patient engagement offerings
  • Providers accounted for the highest market share in the end-use segment while the application segment was dominated by health management in 2020
  • In the therapeutic area, the chronic disease segment held the largest revenue share in 2020, owing to an aging population and lifestyle factors. According to the CDC, every 6 in 10 Americans live with at least one chronic disease
  • Diabetes and heart disease are some of the key chronic diseases. As per CDC’s 2020 report on National Diabetes Statistics, around 34.2 million Americans were diabetic
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • athenahealth, Inc.
  • Force Therapeutics LLC
  • Greenway Health, LLC
  • IQVIA
  • Lincor
  • Medecision
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates & Forecast Timeline
1.1.3 Research Scope and Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:

Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 U.S. Patient Engagement Solutions Market Outlook, 2016-2028 (USD Million)
2.2 U.S. Patient Engagement Solutions Market Summary, 2020

Chapter 3 Market Variables, Trends & Scope
3.1 U.S. Patient Engagement Solutions Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Rising Geriatric Population
3.1.3 Increasing Prevalence of Chronic Conditions
3.1.3.1 Neurological disorders
3.1.3.2 Cancer
3.1.3.3 Type 2 diabetes
3.1.4 Favorable Government Initiatives
3.1.5 Increasing Use of Mobile Health
3.1.6 Increasing Investments by Stakeholders
3.1.7 Market Restraint Analysis
3.1.8 Protection of Patient Information
3.1.9 Requirement for Infrastructure
3.2 Penetration & Growth Prospect Mapping
3.3 U.S. Patient Engagement Solutions Market Analysis Tools: Porter’s Five Forces Analysis
3.4 U.S. Patient Engagement Solutions: SWOT Analysis by Factors (Political & Legal, Economic, Social and Technological)
3.5 Target Audience
3.5.1 List of Key Buyers
3.6 Buyer’s Preference Analysis
3.7 Potential Target Audience
3.8 Changing Technology & Their Adoption
3.8.1 Adoption Rate of Changing Technology
3.8.2 Timeline with Major Technology Changes
3.9 Product & Service Analysis

Chapter 4 U.S. Patient Engagement Solutions Market: Covid-19 Impact
4.1 Impact of COVID-19 on the U.S. Patient Engagement Solutions Application Market
4.2 Regulatory/Policy Changes
4.3 Opportunity Analysis
4.3.1 Increasing Government Initiatives
4.4 Strategies Adopted by Market Players

Chapter 5 U.S. Patient Engagement Solutions Market: Delivery Type Estimates & Trend Analysis
5.1 Delivery Type Market Share Analysis, 2020 & 2028
5.2 Delivery Type Dashboard
5.3 Web-based
5.3.1 Web-based market estimates and forecasts, 2016 - 2028 (USD Million)
5.4 Cloud-based
5.4.1 Cloud-based market estimates and forecasts, 2016 - 2028 (USD Million)
5.5 On-premise
5.5.1 On-premise market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 6 U.S. Patient Engagement Solutions Market: Component Estimates & Trend Analysis
6.1 Component Market Share Analysis, 2020 & 2028
6.2 Component Dashboard
6.3 Software
6.3.1 Software market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.2 Standalone Software
6.3.2.1 Standalone software market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.3 Integrated Software
6.3.3.1 Integrated software market estimates and forecasts, 2016 - 2028 (USD Million)
6.4 Hardware
6.4.1 Hardware market estimates and forecasts, 2016 - 2028 (USD Million)
6.5 Services
6.5.1 Services market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.2 Consulting
6.5.2.1 Consulting services market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.3 Implementation
6.5.3.1 Implementation services market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.4 Education
6.5.4.1 Educational services market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.5 Other Services
6.5.5.1 Other services market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 7 U.S. Patient Engagement Solutions Market: Application Estimates & Trend Analysis
7.1 Application Market Share Analysis, 2020 & 2028
7.2 Application Dashboard
7.3 Social Management
7.3.1 Social management market estimates and forecasts, 2016 - 2028 (USD Million)
7.4 Health Management
7.4.1 Health management market estimates and forecasts, 2016 - 2028 (USD Million)
7.5 Home Healthcare Management
7.5.1 Home healthcare market estimates and forecasts, 2016 - 2028 (USD Million)
7.6 Financial Health Management
7.6.1 Financial health management market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 8 U.S. Patient Engagement Solutions Market: End-use Estimates & Trend Analysis
8.1 End-Use Market Share Analysis, 2020 & 2028
8.2 End-use Dashboard
8.3 Providers
8.3.1 Providers market estimates and forecasts, 2016 - 2028 (USD Million)
8.4 Payers
8.4.1 Payers market estimates and forecasts, 2016 - 2028 (USD Million)
8.5 Individual Users
8.5.1 Individual users market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 9 U.S. Patient Engagement Solutions Market: Therapeutic Area Estimates & Trend Analysis
9.1 Therapeutic Area Market Share Analysis, 2020 & 2028
9.2 Therapeutic Area Dashboard
9.3 Chronic Diseases
9.3.1 Chronic diseases market estimates and forecasts, 2016 - 2028 (USD Million)
9.3.2 Diabetes
9.3.2.1 Diabetes market estimates and forecasts, 2016 - 2028 (USD Million)
9.3.3 Cardiovascular Diseases
9.3.3.1 Cardiovascular diseases market estimates and forecasts, 2016 - 2028 (USD Million)
9.3.4 Obesity
9.3.4.1 Obesity market estimates and forecasts, 2016 - 2028 (USD Million)
9.4 Women’s Health
9.4.1 Women’s health market estimates and forecasts, 2016 - 2028 (USD Million)
9.5 Mental Health
9.5.1 Mental health market estimates and forecasts, 2016 - 2028 (USD Million)
9.6 Fitness
9.6.1 Fitness market estimates and forecasts, 2016 - 2028 (USD Million)
9.7 Other Therapeutic Areas
9.7.1 Other therapeutic areas market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 10 Competitive Landscape
10.1 Strategy Framework
10.2 Company Profiles
10.2.1 Allscripts Healthcare, LLC
10.2.1.1 Company Overview
10.2.1.2 Financial Performance
10.2.1.3 Product Benchmarking
10.2.1.4 Strategic Initiatives
10.2.2 Orion Health
10.2.2.1 Company Overview
10.2.2.2 Financial Performance
10.2.2.3 Product Benchmarking
10.2.2.4 Strategic Initiatives
10.2.3 Cerner Corporation
10.2.3.1 Company Overview
10.2.3.2 Financial Performance
10.2.3.3 Product Benchmarking
10.2.3.4 Strategic Initiatives
10.2.4 McKesson Corporation
10.2.4.1 Company Overview
10.2.4.2 Financial Performance
10.2.4.3 Product Benchmarking
10.2.4.4 Strategic Initiatives
10.2.5 athenahealth, Inc.
10.2.5.1 Company Overview
10.2.5.2 Financial Performance
10.2.5.3 Product Benchmarking
10.2.5.4 Strategic Initiatives
10.2.6 IBM
10.2.6.1 COMPANY Overview
10.2.6.2 Financial Performance
10.2.6.3 Product Benchmarking
10.2.6.4 Strategic Initiatives
10.2.7 Medecision
10.2.7.1 Company Overview
10.2.7.2 Financial Performance
10.2.7.3 Product Benchmarking
10.2.7.4 Strategic Initiatives
10.2.8 GetWellNetwork, Inc.
10.2.8.1 Company Overview
10.2.8.2 Financial Performance
10.2.8.3 Product Benchmarking
10.2.8.4 Strategic Initiatives
10.2.9 MEDHOST
10.2.9.1 Company Overview
10.2.9.2 Financial Performance
10.2.9.3 Product Benchmarking
10.2.9.4 Strategic Initiatives
10.2.10 Lincor
10.2.10.1 Company Overview
10.2.10.2 Financial Performance
10.2.10.3 Product Benchmarking
10.2.10.4 Strategic Initiatives
10.2.11 IQVIA
10.2.11.1 Company Overview
10.2.11.2 Financial Performance
10.2.11.3 Product Benchmarking
10.2.11.4 Strategic Initiatives
10.2.12 Wolters Kluwer N.V.
10.2.12.1 Company Overview
10.2.12.2 Financial Performance
10.2.12.3 Product Benchmarking
10.2.12.4 Strategic Initiatives
10.2.13 Force Therapeutics LLC
10.2.13.1 Company Overview
10.2.13.2 Financial Performance
10.2.13.3 Product Benchmarking
10.2.13.4 Strategic Initiatives
10.2.14 Quil
10.2.14.1 Company Overview
10.2.14.2 Product Benchmarking
10.2.14.3 Strategic Initiatives
10.2.15 Greenway Health, LLC
10.2.15.1 Company Overview
10.2.15.2 Financial Performance
10.2.15.3 Product Benchmarking
10.2.15.4 Strategic Initiatives
10.2.16 Mytonomy
10.2.16.1 Company Overview
10.2.16.2 Financial Performance
10.2.16.3 Product Benchmarking
10.2.16.4 Strategic Initiatives
10.2.17 Klara Technologies, Inc.
10.2.17.1 Company Overview
10.2.17.2 Financial Performance
10.2.17.3 Product Benchmarking
10.2.17.4 Strategic Initiatives
10.2.18 Solutionreach, Inc.
10.2.18.1 Company Overview
10.2.18.2 Financial Performance
10.2.18.3 Product Benchmarking
10.2.18.4 Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America geriatric population (Over 60 Years) (Million) (2014-2024)
Table 4 Total Numbers of Americans Aged 65 and Older with Alzheimer's Dementia
Table 5 North America diabetes prevalence (national prevalence %), 2013 & 2035
Table 6 Product heat map analysis: Patient Education Solutions
Table 7 U.S. Patient Engagement Solutions Market, by delivery type, 2016 - 2028 (USD Million)
Table 8 U.S. Patient Engagement Solutions Market, by component, 2016 - 2028 (USD Million)
Table 9 U.S. Patient Engagement Solutions Software Market, by component, 2016 - 2028 (USD Million)
Table 10 U.S. Patient Engagement Solutions Market, by services type, 2016 - 2028 (USD Million)
Table 11 U.S. Patient Engagement Solutions Market, by end-use, 2016 - 2028 (USD Million)
Table 12 U.S. Patient Engagement Solutions Market, by application, 2016 - 2028 (USD Million)
Table 13 U.S. Patient Engagement Solutions Market, by therapeutic area, 2016 - 2028 (USD Million)
Table 14 U.S. Patient Engagement Solutions Therapeutic Area Market, by chronic diseases, 2016 - 2028 (USD Million)

List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow analysis
Fig. 10 U.S. Patient Engagement Solutions market revenue (USD Million)
Fig. 11 U.S. Patient Engagement Solutions Market Snapshot
Fig. 12 U.S. Patient Engagement Solutions market dynamics
Fig. 13 U.S. Patient Engagement Solutions market driver impact
Fig. 14 U.S. Patient Engagement Solutions market restraint impact
Fig. 15 Penetration & growth prospect mapping
Fig. 16 U.S. Patient engagement solutions Porter’s analysis
Fig. 17 U.S. Patient engagement solutions - SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 18 Parameters considered prior to U.S. Patient engagement solution selection
Fig. 19 Changing method
Fig. 20 Reasons for replacing existing software
Fig. 21 Time frame for EHR implementation
Fig. 22 Buyers’ integration requirement
Fig. 23 Buyers’ deployment preference
Fig. 24 Technology timeline analysis
Fig. 25 Market participants wise pipe analysis with expected launch date
Fig. 26 U.S. patient engagement solutions market: Delivery type movement analysis
Fig. 27 U.S. Patient Engagement Solutions Market: Delivery Type Dashboard
Fig. 28 Web-based market, 2016 - 2028 (USD Million)
Fig. 29 Cloud-based market, 2016 - 2028 (USD Million)
Fig. 30 On-premise market, 2016 - 2028 (USD Million)
Fig. 31 U.S. Patient Engagement Solutions market: Component movement analysis
Fig. 32 U.S. Patient Engagement Solutions Market: Component Dashboard
Fig. 33 Software market, 2016 - 2028 (USD Million)
Fig. 34 Standalone software market, 2016 - 2028 (USD Million)
Fig. 35 Integrated software market, 2016 - 2028 (USD Million)
Fig. 36 Hardware market, 2016 - 2028 (USD Million)
Fig. 37 Services market, 2016 - 2028 (USD Million)
Fig. 38 Consulting services market, 2016 - 2028 (USD Million)
Fig. 39 Implementation services market, 2016 - 2028 (USD Million)
Fig. 40 Educational services market, 2016 - 2028 (USD Million)
Fig. 41 Other services market, 2016 - 2028 (USD Million)
Fig. 42 U.S. Patient Engagement Solutions Market: Application movement analysis
Fig. 43 U.S. Patient Engagement Solutions Application Dashboard
Fig. 44 Social management market, 2016 - 2028 (USD Million)
Fig. 45 Health management market, 2016 - 2028 (USD Million)
Fig. 46 Home healthcare market, 2016 - 2028 (USD Million)
Fig. 47 Financial health management market, 2016 - 2028 (USD Million)
Fig. 48 U.S. Patient Engagement Solutions market: End-use movement analysis
Fig. 49 U.S. Patient Engagement Solutions Market: End-use Dashboard
Fig. 50 Providers market, 2016 - 2028 (USD Million)
Fig. 51 Payers market, 2016 - 2028 (USD Million)
Fig. 52 Individual users market, 2016 - 2028 (USD Million)
Fig. 53 U.S. Patient Engagement Solutions market: Therapeutic area movement analysis
Fig. 54 U.S. Patient Engagement Solutions Market: Therapeutic Area Dashboard
Fig. 55 Chronic diseases market, 2016 - 2028 (USD Million)
Fig. 56 Diabetes market, 2016 - 2028 (USD Million)
Fig. 57 Cardiovascular diseases market, 2016 - 2028 (USD Million)
Fig. 58 Obesity market, 2016 - 2028 (USD Million)
Fig. 59 Women’s health market, 2016 - 2028 (USD Million)
Fig. 60 Mental health market, 2016 - 2028 (USD Million)
Fig. 61 Fitness market, 2016 - 2028 (USD Million)
Fig. 62 Other therapeutic areas market, 2016 - 2028 (USD Million)
Fig. 63 Strategy framework
Note: Product cover images may vary from those shown
  • Allscripts Healthcare, LLC
  • Orion Health
  • Cerner Corporation
  • McKesson Corporation
  • athenahealth, Inc.
  • IBM
  • Medecision
  • GetWellNetwork, Inc.
  • MEDHOST
  • Lincor
  • IQVIA
  • Wolters Kluwer N.V.
  • Force Therapeutics LLC
  • Quil
  • Greenway Health, LLC
  • Mytonomy
  • Klara Technologies, Inc.
  • Solutionreach, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll